The results of a new study, published in Nature Medicine, could make life easier for people taking part in clinical trials by reducing visits to a clinic for in-person assessments.
The results of a new study, published in Nature Medicine, could make life easier for people taking part in clinical trials by reducing visits to a clinic for in-person assessments.
A promising and much-needed tuberculosis (TB) treatment is advancing through clinical trials thanks to support from European partnerships IMI2 and EDCTP.
IMI's RHAPSODY project researchers have split type 2 diabetes into subgroups and are working on a tool to personalise treatment for the disease. Their aim is to help patients get...
IHI's brokerage event provided people interested in IHI call 9 with an excellent opportunity to network and start forming consortia.
The two organisations have signed a Memorandum of Understanding that will facilitate collaboration and allow them to leverage their strengths, networks and expertise.
LITMUS is studying how simple blood tests or scans could replace surgical biopsies as a means to identify people with the liver disease non-alcoholic staetohepatitis (NASH).
The INNODIA project is launching four diabetes drug studies, designed according to their regulator-approved master protocol